Headquartered in North Carolina, Stallergenes Greer’s business in the United States is part of a leading global biopharmaceutical company specializing in the development and commercialization of allergy immunotherapy (AIT) products and services for use in the diagnosis and treatment of allergies. This page is intended for US Healthcare Provider audiences. See our community guidelines here: http://bit.ly/3drWSql
